We are pleased to share Aktiespararna’s article highlighting Ziccum’s LaminarPace® technology. The article focuses on Ziccum’s great potential when it comes to helping biopharmaceuticals to realization and the mRNA revolution, informative background of the company, current business model and promising market outlook, and information about its recently announced rights issue.
Please follow the link to read the full article (in Swedish) here: En teknologiplattform helt rätt i tiden | Aktiespararna